Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medicenna Therapeutics Corp. - Common Shares (NQ:MDNA)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Nov 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.1510 (5)
Ask (Size) 0.1565 (181)
Prev. Close 0.1570
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 69,637,469
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Dear LUNR Stock Fans, Mark Your Calendars for Jan. 12 ↗
Intuitive Machines stock is rising on Monday after the company announced plans for a lunar mission launch in January 2024. 
Via InvestorPlace
News headline image
Why Is Medicenna Therapeutics (MDNA) Stock Down Today? ↗
Medicenna Therapeutics stock is falling on Monday after the company announced that shares of MDNA will be delisted from the Nasdaq. 
Via InvestorPlace

Performance

More News

Read More
News headline image
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
Via InvestorPlace
News headline image
The Latest Analyst Ratings for Medicenna Therapeutics ↗
Via Benzinga
News headline image
Medicenna Therapeutics's Earnings: A Preview ↗
Via Benzinga
News headline image
Earnings Preview For Medicenna Therapeutics ↗
Via Benzinga
News headline image
Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Via Benzinga
News headline image
Nasdaq Jumps 100 Points; Amazon Posts Upbeat Earnings ↗
Via Benzinga
Topics Stocks
News headline image
Medicenna Therapeutics Earnings Preview ↗
Via Benzinga
News headline image
Medicenna's Lead Cancer Program Shows Preliminary Anti-Cancer Activity In Solid Tumor Study ↗
Via Benzinga
News headline image
Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Could CRISPR Therapeutics Help You Become a Millionaire? ↗
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022 ↗
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Via Benzinga
News headline image
Earnings Scheduled For November 4, 2022 ↗
Via Benzinga
News headline image
Earnings Outlook For Medicenna Therapeutics ↗
Via Benzinga
News headline image
Medicenna Therapeutics: Q1 Earnings Insights ↗
Via Benzinga
News headline image
Recap: Medicenna Therapeutics Q1 Earnings ↗
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Via InvestorPlace
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Via Benzinga
News headline image
Earnings Scheduled For August 15, 2022 ↗
Via Benzinga
News headline image
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗
Via Benzinga
News headline image
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗
Via Benzinga

Frequently Asked Questions

Is Medicenna Therapeutics Corp. - Common Shares publicly traded?
Yes, Medicenna Therapeutics Corp. - Common Shares is publicly traded.
What exchange does Medicenna Therapeutics Corp. - Common Shares trade on?
Medicenna Therapeutics Corp. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Medicenna Therapeutics Corp. - Common Shares?
The ticker symbol for Medicenna Therapeutics Corp. - Common Shares is MDNA on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.